Teva Unit, mAbxience Partner to Develop Anti-PD-1 Oncology Biosimilar-March 2024-www.financetom.com

Teva Unit, mAbxience Partner to Develop Anti-PD-1 Oncology Biosimilar

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Teva Unit, mAbxience Partner to Develop Anti-PD-1 Oncology Biosimilar

Oct 3, 2024 6:35 AM

09:04 AM EDT, 10/03/2024 (MT Newswires) -- Teva Pharmaceutical Industries' ( TEVA ) subsidiary Teva Pharmaceuticals International has partnered with mAbxience to develop an anti-PD-1 oncology biosimilar, the companies said Thursday.

Under the agreement, mAbxience will handle development and production, while Teva will manage regulatory approvals and commercialization, the companies said.

Price: 17.50, Change: +0.04, Percent Change: +0.23

Previous page： PNC Financial Services Group Insider Sold Shares Worth $6,302,568, According to a Recent SEC Filing Next page： Centene Insider Bought Shares Worth $1,000,008, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

PNC Financial Services Group Insider Sold Shares Worth $6,302,568, According to a Recent SEC Filing

Nov 13, 2024

06:15 PM EST, 11/13/2024 (MT Newswires) -- Andrew T Feldstein, Director, on November 11, 2024, sold 30,000 shares in PNC Financial Services Group ( PNC ) for $6,302,568. Following the Form 4 filing with the SEC, Feldstein has control over a total of 90,259 shares of the company, with 38,649 shares held directly and 51,610 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/713676/000162828024047497/xslF345X05/wk-form4_1731520005.xml...

Centene Insider Bought Shares Worth $1,000,008, According to a Recent SEC Filing

Nov 13, 2024

06:18 PM EST, 11/13/2024 (MT Newswires) -- Andrew Lynn Asher, Chief Financial Officer, on November 13, 2024, executed a purchase for 17,200 shares in Centene ( CNC ) for $1,000,008. Following the Form 4 filing with the SEC, Asher has control over a total of 486,847 shares of the company, with 486,847 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1071739/000107173924000210/xslF345X05/wk-form4_1731539233.xml Price: 64.79,...

ADM says top compliance officer is leaving the company

Nov 13, 2024

Nov 13 (Reuters) - Archer-Daniels-Midland Co's ( ADM ) chief compliance officer, Ben Bard, is leaving the company early next year for personal reasons, the company said on Wednesday. The news comes one day after the global grain trader, which has been embroiled in controversy over its accounting practices, sought an extension from the U.S. Securities and Exchange Commission to...

Ameriprise Financial Insider Sold Shares Worth $4,882,780, According to a Recent SEC Filing

Nov 13, 2024

06:19 PM EST, 11/13/2024 (MT Newswires) -- Walter Stanley Berman, Executive VP and CFO, on November 11, 2024, sold 8,655 shares in Ameriprise Financial ( AMP ) for $4,882,780. Following the Form 4 filing with the SEC, Berman has control over a total of 6,769 shares of the company, with 6,409 shares held directly and 360 controlled indirectly. SEC Filing:...